NCT06516146

Brief Summary

The Impact 360 study will evaluate the effects of a combined intervention of exercise, mindfulness, and nutrition on 8 key indicators of health and the mechanisms that drive these changes. 60 subjects aged 50 to 75 without a current diagnosis of a brain disorder will be recruited. This study will follow a partial crossover design. All participants will receive the intervention. Participants randomized into the intervention group after their baseline screening will receive the 6-month intervention. Those randomized into the waitlist group will complete another assessment at the end of the 6-month care as usual phase before receiving the intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Jan 2024Jan 2028

Study Start

First participant enrolled

January 24, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 3, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 23, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2027

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2028

Last Updated

March 23, 2026

Status Verified

February 1, 2026

Enrollment Period

3.1 years

First QC Date

May 3, 2024

Last Update Submit

March 19, 2026

Conditions

Keywords

ExerciseMindfulnessMicrobiomeWell-Being

Outcome Measures

Primary Outcomes (38)

  • Cognition - NIH Toolbox Cognitive Battery

    Cognition will be measured using the National Institutes of Health (NIH) Toolbox Cognitive battery (NIHTB-CB). Testing is done pre- and post-intervention to compare scores.

    6 Months

  • Cognition- Montreal Cognitive Assessment

    Cognition will be measured using the Montreal Cognitive Assessment (MoCA). Testing is done pre- and post-intervention to compare scores.

    6 Months

  • Cognition- Parkinson's Disease Cognitive Rating Scale

    Cognition will be measured using the Parkinson's Disease Cognitive Rating Scale (PD-CRS). Testing is done pre- and post-intervention to compare scores.

    6 Months

  • Inflammation and Biomarkers in Serum- High Sensitivity C-Reactive Protein

    Systemic inflammation will be assessed by measuring concentrations of high sensitivity C-reactive protein (hs-CRP). Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - Interleukin-1β

    Systemic inflammation will be assessed by measuring concentrations of interleukin-1β (IL-1β). Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - Interleukin-6

    Systemic inflammation will be assessed by measuring concentrations of interleukin-6 (IL-6). Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - Tumour Necrosis Factor Alpha

    Systemic inflammation will be assessed by measuring concentrations of Tumour Necrosis Factor Alpha (TNFa). Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - Interleukin-8

    Systemic inflammation will be assessed by measuring concentrations of interleukin-8 (IL-8). Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - Interleukin-10

    Systemic inflammation will be assessed by measuring concentrations of interleukin-10 (IL-10). Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - Interleukin-18

    Systemic inflammation will be assessed by measuring concentrations of interleukin-18 (IL-18). Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - Calprotectin

    Systemic inflammation will be assessed by measuring concentrations of calprotectin. Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Inflammation and Biomarkers in Serum - cortisol

    Systemic inflammation will be assessed by measuring concentrations of cortisol. Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Microbiome Diversity

    Stool samples will be analyzed for gut microbiome composition by shallow shotgun metagenome sequencing. Samples will be taken pre- and post-intervention to assess changes.

    6 Months

  • Sleep Efficiency

    Sleep efficiency (total sleep time/time spent in bed) will be measured through a wearable device with an accelerometer. This device will also measure other components of sleep quality such as sleep onset latency, total sleep time and wake after sleep onset.

    6 Months

  • Pittsburgh Sleep Quality Index

    The Pittsburgh Sleep Quality Index will be used to collect subjective sleep quality data on a monthly basis.

    6 Months

  • Total Grey Matter Volume

    Total grey matter volume will be measured using an MRI. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Hippocampal Volume

    Hippocampal volume will be measured using an MRI. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • White matter hyperintensities volume

    White matter hyperintensities volume will be measured using an MRI. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Myelin Water

    Myelin water imaging will be collected using resting state functional MRI. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Functional MRI

    A flanker task will be administered during the MRI to examine selective attention, inhibitory function, and executive control. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Maximal oxygen consumption (VO2 Max)

    Predicted maximal oxygen consumption will be measured using a six-minute walk test. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Heart Rate Recovery

    Heart rate recovery will be measured using a three-minute step test. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Berg Balance Assessment

    A Berg Balance Assessment will be used to measure participants balance. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Dynamic Gate Index

    The Dynamic Gait Index will be used to measure participants gait. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Timed Up and Go Test

    The Dynamic Gait Index will be used to measure participants gait. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • 30 Second Sit to Stand Test

    Functional lower extremity strength with be assessed using the 30 second sit to stand test. Testing is done pre- and post-intervention to compare scores.

    6 Months

  • Dual-Energy X-Ray Absorptiometry (DEXA)

    Body composition, such as body fat and muscle mass, will be measured using Dual-energy X-ray Absorptiometry. Testing is done pre- and post-intervention to compare scores.

    6-Months

  • Physical Activity Levels

    Physical activity levels will be measured through a wearable device to help ensure adherence and effectiveness of the exercise intervention. Data will be collected throughout the study.

    6 Months

  • Heart Rate

    Heart rate will be measured through a wearable device to help ensure adherence and effectiveness of the exercise intervention. Data will be collected throughout the study.

    6 Months

  • Fried Frailty Index

    Physical frailty will be assessed using the fried frailty index. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Blood Pressure

    Blood pressure will be measured pre- and post-intervention to compares scores.

    6 Months

  • Weight

    Weight will be measured pre- and post-intervention to compares scores.

    6 Months

  • Framingham Risk Score

    Cardiovascular health will be assessed using the Framingham Risk Score. This score includes measurements of age, total cholesterol, smoking status, HDL level, diabetes status, systolic blood pressure and treatment status. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • NIH Toolbox- Emotional Battery

    Social, emotional, and mental well-being will be evaluated using the NIH Toolbox-Emotional Battery. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • World Health Organization (WHO) Quality of Life Questionnaire

    Quality of life will be evaluated using the World Health Organization (WHO) Quality of Life Questionnaire. Testing is done pre- and post-intervention to compares scores.

    6 Months

  • Freiburg Mindfulness Inventory

    Questionnaires related to mindfulness will be administered throughout the study at monthly intervals.

    6 Months

  • Mindful Attention Awareness Scale

    Questionnaires related to mindfulness will be administered throughout the study at monthly intervals.

    6 Months

  • Multidimensional Assessment of Interoceptive Awareness

    Questionnaires related to mindfulness will be administered throughout the study at monthly intervals.

    6 Months

Study Arms (2)

Exercise, Diet, Mindfulness

EXPERIMENTAL

The intervention group will start the intervention immediately following their baseline assessment. They will undergo another assessment after the 6 month intervention period.

Behavioral: ExerciseBehavioral: MeditationBehavioral: Diet

Waitlist Group

NO INTERVENTION

Participants randomized into the waitlist group will undergo a baseline assessment, and will then be encouraged to continue their daily activities as usual for 6 months. Physical activity and sleep will be monitored during this time using wearable devices. Links to questionnaires will be emailed monthly. After the 6-month waitlist period, participants will undergo a second assessment prior to starting the intervention. The multimodal intervention will be 6-months in length, using the same measures of adherence, and will be followed by a final assessment.

Interventions

ExerciseBEHAVIORAL

The intervention will involve online (via University of British Colombia (UBC) Zoom videoconferencing) 1-hour moderate to high intensity exercise classes 3 times a week for 6 months

Exercise, Diet, Mindfulness
MeditationBEHAVIORAL

The intervention will involve 15 minute guided mediation following exercise classes as well as mindfulness classes. Mindfulness classes will consist of 1.5 hour Mindfulness Based Stress Reduction (MBSR) classes for the first 2 months, followed by 1 month of 1 hour bi-weekly discussions and practice, then MBSR 2.0 for months 4 and 5, and 1 hour bi-weekly discussions and practice for the remaining month of the intervention.

Exercise, Diet, Mindfulness
DietBEHAVIORAL

The intervention will involve biweekly 1-hour nutrition and cooking classes with a dietician.

Exercise, Diet, Mindfulness

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants who are able to complete questionnaires and follow directions for interventions
  • Have access to a smartphone that can support the Fitbit app

You may not qualify if:

  • Any neurological disease/disorder diagnosis (Ex: Parkinson's Disease, Multiple Sclerosis, Traumatic Brain Injury, Brain lesion, Stroke, etc)
  • Any chronic medical condition which would affect ability to participate in exercise
  • Any contraindication for exercise based on the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and medical clearance form
  • Participants who were told by a medical doctor that they need to be medically supervised for exercise
  • Montreal Cognitive Assessment (MoCA) scores \<21/30
  • Significant cognitive impairment, depression, or eating disorder
  • Any contraindication to MRI scanning; such as implanted metal clips or wires (see list below)
  • Participants currently doing 180 minutes or more of moderate-vigorous intensity exercise per week AND either of the following:
  • Completion of an Mindfulness-Based Stress Reduction course OR; Score \>8/15 in the Mediterranean-Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) Diet Questionnaire
  • Significant or unstable cardiovascular or respiratory disease
  • Severe/multiple head trauma(s)
  • Subjects who are pregnant or breastfeeding
  • Subjects with a history or major episodes of drug or alcohol abuse
  • Chronic/acute bacterial/viral infection
  • GI cancer
  • +16 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Colombia

Vancouver, British Columbia, V6T 1Z3, Canada

RECRUITING

MeSH Terms

Conditions

Motor Activity

Interventions

ExerciseMeditationDiet

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaMind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Silke Appel-Cresswell, MD, FRCPC

    University of British Colombia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeffrey Kelly, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Adults 50-75 years of age without a diagnosis of a neurodegenerative condition, will be recruited and screened for eligibility. Sixty participants will be randomly assigned to the waitlist group or the intervention group and will be striated into cohorts blocks. Each cohort block will start the intervention at the same time and will participate in the intervention together. This will allow for social interaction, engagement with their peers, and hopefully encouraging better adherence.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 3, 2024

First Posted

July 23, 2024

Study Start

January 24, 2024

Primary Completion (Estimated)

February 20, 2027

Study Completion (Estimated)

January 5, 2028

Last Updated

March 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations